Schedule 13G ownership disclosure
MYnd Analytics, Inc.
Security class unavailable · CUSIP: 62857N202
Event date: 2019-07-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-016588
- Form type
- SC 13G
- Filer
- Emmaus Life Sciences, Inc.
- CIK
- CIK 822370
- Filed
- Aug 23, 2019
- Reporting period
- Jul 22, 2019
- Description
- Schedule 13G beneficial ownership